Liquidia (LQDA) Retained Earnings (2019 - 2026)
Liquidia (LQDA) posted quarterly Retained Earnings of -$573.5 million for Q1 2026, up 3.75% year-over-year from -$552.7 million in Q1 2025, and down 185.47% quarter-over-quarter from $671.0 million in Q4 2025.
Liquidia (LQDA) Retained Earnings (2019 - 2026) Analysis & Trends
Liquidia's Retained Earnings history runs 8 years deep, the most recent figure standing at -$573.5 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 3.75% year-over-year to -$573.5 million; the TTM figure through Mar 2026 stood at -$573.5 million (up 3.75% YoY), while the FY2025 annual figure was $671.0 million, up 5.39% from the prior year.
- Retained Earnings for Q1 2026 stood at -$573.5 million, down from $671.0 million in the prior quarter.
- The five-year high for Retained Earnings was $671.0 million in Q4 2025, with the low at -$637.3 million in Q2 2025.
- The 5-year median for Retained Earnings is $380.9 million (2022), against an average of $67.8 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings jumped 257.26% in 2024, then plunged 213.69% in 2025.
- Liquidia's Retained Earnings stood at -$350.6 million in 2022, then surged by 235.86% to $476.3 million in 2023, then surged by 33.67% to $636.7 million in 2024, then increased by 5.39% to $671.0 million in 2025, then slumped by 185.47% to -$573.5 million in 2026.
- Business Quant data shows LQDA's Retained Earnings at -$573.5 million in Q1 2026, $671.0 million in Q4 2025, and $662.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Liquidia | 6.31 Bn | 6.03 Bn | 160.92 Mn | 693.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 693.75 Mn |
| Mar 31, 2026 | -573.45 Mn |
| Dec 31, 2025 | 670.97 Mn |
| Sep 30, 2025 | 662.83 Mn |
| Jun 30, 2025 | -637.34 Mn |
| Mar 31, 2025 | -595.80 Mn |
| Dec 31, 2024 | 636.68 Mn |
| Sep 30, 2024 | 631.56 Mn |
| Jun 30, 2024 | 560.61 Mn |
| Mar 31, 2024 | -459.18 Mn |
| Dec 31, 2023 | 476.32 Mn |
| Sep 30, 2023 | -401.60 Mn |
| Jun 30, 2023 | -385.86 Mn |
| Mar 31, 2023 | 443.92 Mn |
| Dec 31, 2022 | -350.60 Mn |
| Sep 30, 2022 | -344.10 Mn |
| Jun 30, 2022 | 437.01 Mn |
| Mar 31, 2022 | 380.86 Mn |
| Dec 31, 2021 | -309.58 Mn |
| Sep 30, 2021 | 370.93 Mn |